Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584437 | PMC |
http://dx.doi.org/10.18632/oncotarget.28292 | DOI Listing |
Autophagy
July 2024
Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.
Ther Adv Med Oncol
April 2024
Division of Hematology/Oncology, Fred Hutchinson Cancer Center, University of Washington School of Medicine, Seattle, WA, USA.
The introduction of immunotherapy has revolutionized the treatment and improved outcomes of multiple types of cancer. Although breast cancer is a less immune-responsive tumor type, the incorporation of pembrolizumab into chemotherapy regimens in the neoadjuvant and first-line metastatic setting for the triple-negative disease has improved outcomes. However, the use of this type of treatment is associated with a spectrum of adverse events.
View Article and Find Full Text PDFBiomed Phys Eng Express
February 2024
Department of Radiation Oncology, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, United States of America.
In an addendum to AAPM TG-51 protocol, McEwen, (DOI:10.1118/1.4866223) introduced a new factorto account for the radial dose distribution of the photon beam over the detector volume mainly in flattening filter free (FFF) beams.
View Article and Find Full Text PDFOncotarget
October 2022
Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
Sci Data
September 2021
Department of Zoology, University of Cambridge, Downing Street, Cambridge, CB2 3EJ, United Kingdom.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!